Subject
Chemical Health and Safety,Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,Safety Research,General Medicine
Reference17 articles.
1. Department of Health and Human Services. Office of the Inspector General. Changes made to state’s Medicaid programs to ensure beneficiary access to prescriptions during the COVID-19 pandemic; 2020. Available from: https://oig.hhs.gov/oas/reports/region6/62004007.pdf. Accessed: January 28, 2023.
2. Delay or Avoidance of Medical Care Because of COVID-19–Related Concerns — United States, June 2020
3. Centers for Medicaid and Medicare. National Medicaid Fee-For-Service (FFS), FFY 2020 Drug Utilization Review (DUR) Annual Report. Available from: https://www.medicaid.gov/medicaid/prescription-drugs/downloads/2020-dur-ffs-summary-report.pdf. Accessed January 30, 2023.
4. An Epidemic in the Midst of a Pandemic: Opioid Use Disorder and COVID-19
5. Vital Signs: Characteristics of Drug Overdose Deaths Involving Opioids and Stimulants — 24 States and the District of Columbia, January–June 2019